L2L L2L Microarray Analysis Tool

Results for A01AB.profile.u50

Results summary View all lists in GO:BiolProc View all genes in A01AB.profile.u50
List Name Description Total
probes
Expected
matches
Actual
matches
Fold
Enrichment
Binomial
p-value
regulation of chemotaxis Any process that modulates the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient. 16 0.04 2 50.57 7.17e-04
in utero embryonic development The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. 70 0.17 3 17.34 7.31e-04
eye photoreceptor cell differentiation The process whereby a relatively unspecialized cell acquires the specialized features of a photoreceptor cell, as found in the eye, the primary visual organ of most organisms. 19 0.05 2 42.58 1.02e-03
eye photoreceptor cell development Development of a photoreceptor, a sensory cell in the eye that reacts to the presence of light. They usually contain a pigment that undergoes a chemical change when light is absorbed, thus stimulating a nerve. 19 0.05 2 42.58 1.02e-03
photoreceptor cell development Development of a photoreceptor, a cell that responds to incident electromagnetic radiation, particularly visible light. 20 0.05 2 40.45 1.13e-03
photoreceptor cell differentiation The specialization of organization of a photoreceptor, a cell that responds to incident electromagnetic radiation, particularly visible light. 20 0.05 2 40.45 1.13e-03
response to unfolded protein A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus. 83 0.21 3 14.62 1.20e-03
response to protein stimulus A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein stimulus. 83 0.21 3 14.62 1.20e-03
negative regulation of microtubule depolymerization Any process that stops, prevents or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol. 25 0.06 2 32.36 1.77e-03
regulation of microtubule depolymerization Any process that modulates the frequency, rate or extent of microtubule depolymerization. 25 0.06 2 32.36 1.77e-03
positive regulation of epithelial cell proliferation Any process that activates or increases the rate or extent of epithelial cell proliferation. 25 0.06 2 32.36 1.77e-03
microtubule depolymerization The removal of tubulin heterodimers from one or both ends of a microtubule. 27 0.07 2 29.97 2.06e-03
regulation of microtubule polymerization or depolymerization Any process that modulates the frequency, rate or extent of microtubule polymerization or depolymerization by the addition or removal of tubulin heterodimers from a microtubule. 27 0.07 2 29.97 2.06e-03
negative regulation of microtubule polymerization or depolymerization Any process that stops, prevents or reduces the frequency, rate or extent of microtubule polymerization or depolymerization. 27 0.07 2 29.97 2.06e-03
vasculogenesis The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes. 30 0.07 2 26.97 2.54e-03
microtubule polymerization or depolymerization Assembly or disassembly of microtubules by the addition or removal of tubulin heterodimers from a microtubule. 30 0.07 2 26.97 2.54e-03
gluconeogenesis The formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol. 31 0.08 2 26.10 2.71e-03
pyruvate metabolic process The chemical reactions and pathways involving pyruvate, 2-oxopropanoate. 32 0.08 2 25.28 2.88e-03
eye morphogenesis The process by which the anatomical structures of the eye are generated and organized. Morphogenesis pertains to the creation of form. 33 0.08 2 24.52 3.07e-03
carbohydrate biosynthetic process The chemical reactions and pathways resulting in the formation of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. 120 0.30 3 10.11 3.42e-03
regulation of epithelial cell proliferation Any process that modulates the frequency, rate or extent of epithelial cell proliferation. 35 0.09 2 23.12 3.44e-03
epithelial cell proliferation The multiplication or reproduction of epithelial cells, resulting in the rapid expansion of a cell population. Epithelial cells make up the epithelium, the covering of internal and external surfaces of the body, including the lining of vessels and other small cavities. It consists of cells joined by small amounts of cementing substances. 36 0.09 2 22.47 3.64e-03
hexose biosynthetic process The chemical reactions and pathways resulting in the formation of hexose, any aldose with a chain of six carbon atoms in the molecule. 39 0.10 2 20.75 4.26e-03
alcohol biosynthetic process The chemical reactions and pathways resulting in the formation of alcohols, any of a class of alkyl compounds containing a hydroxyl group. 39 0.10 2 20.75 4.26e-03
monosaccharide biosynthetic process The chemical reactions and pathways resulting in the formation of monosaccharides, polyhydric alcohols containing either an aldehyde or a keto group and between three to ten or more carbon atoms. 39 0.10 2 20.75 4.26e-03
cellular biosynthetic process The chemical reactions and pathways resulting in the formation of substances, carried out by individual cells. 811 2.00 7 3.49 4.53e-03
chordate embryonic development The process whose specific outcome is the progression of the embryo over time, from zygote formation through a stage including a notochord and neural tube until birth or egg hatching. 136 0.34 3 8.92 4.85e-03
embryonic development ending in birth or egg hatching The process whose specific outcome is the progression of an embryo over time, from zygote formation until the end of the embryonic life stage. The end of the embryonic life stage is organism-specific and may be somewhat arbitrary; for mammals it is usually considered to be birth, for insects the hatching of the first instar larva from the eggshell. 137 0.34 3 8.86 4.95e-03
amino acid and derivative metabolic process The chemical reactions and pathways involving amino acids, organic acids containing one or more amino substituents, and compounds derived from amino acids. 440 1.09 5 4.60 5.12e-03
response to hypoxia A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. 43 0.11 2 18.82 5.16e-03
response to biotic stimulus A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a biotic stimulus, a stimulus caused or produced by a living organism. 282 0.70 4 5.74 5.59e-03
eye development The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight. 48 0.12 2 16.86 6.39e-03
cell morphogenesis Any process that modulates the mass, volume, or shape of a cell. 668 1.65 6 3.63 6.91e-03
cellular structure morphogenesis The process by which cellular structures are generated and organized. Morphogenesis pertains to the creation of form. 668 1.65 6 3.63 6.91e-03
carboxylic acid metabolic process The chemical reactions and pathways involving carboxylic acids, any organic acid containing one or more carboxyl (COOH) groups or anions (COO-). 679 1.68 6 3.57 7.46e-03
epithelial cell differentiation The process whereby a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium. 52 0.13 2 15.56 7.46e-03
organic acid metabolic process The chemical reactions and pathways involving organic acids, any acidic compound containing carbon in covalent linkage. 681 1.68 6 3.56 7.56e-03
transition metal ion homeostasis The regulation of the levels, transport, and metabolism of transition metal ions within a cell or between a cell and its external environment. A transition metal is an element whose atom has an incomplete d-subshell of extranuclear electrons, or which gives rise to a cation or cations with an incomplete d-subshell. Transition metals often have more than one valency state. Biologically relevant transition metals include vanadium, manganese, iron, copper, cobalt, nickel, molybdenum and silver. 55 0.14 2 14.71 8.32e-03

Raw data (tab-delimited .txt)